Evidence map›Paper›PMID 40272387›Full record

ArticleThe Journal of general physiology2025

Prediction and biological significance of small changes in binding of leiomodin to tropomyosin.

Eduardo Sánchez Díaz, Brayan Osegueda, Svetlana Minakhina, Nickolas Starks, Stefanie Novak, Dmitri Tolkatchev, Carol C Gregorio, Alla S Kostyukova, Garry E Smith

Abstract read
In one paragraph

Article in The Journal of general physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eduardo Sánchez DíazVoiland School of Chemical Engineering and Bioengineering, Washington State University , Pullman, WA, USA.ORCID 0000-0002-1508-5380
Brayan Osegueda *Voiland School of Chemical Engineering and Bioengineering, Washington State University , Pullman, WA, USA.ORCID 0000-0002-9281-8357
Svetlana Minakhina *Department of Medicine and Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3879-7751
Nickolas Starks *Voiland School of Chemical Engineering and Bioengineering, Washington State University , Pullman, WA, USA.
Stefanie NovakDepartment of Cellular and Molecular Medicine and Sarver Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA.ORCID 0009-0005-4737-3175
Dmitri TolkatchevVoiland School of Chemical Engineering and Bioengineering, Washington State University , Pullman, WA, USA.ORCID 0000-0002-1300-6458
Carol C GregorioDepartment of Medicine and Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-0044-2074
Alla S KostyukovaVoiland School of Chemical Engineering and Bioengineering, Washington State University , Pullman, WA, USA.ORCID 0000-0002-6724-2069
Garry E SmithVoiland School of Chemical Engineering and Bioengineering, Washington State University , Pullman, WA, USA.ORCID 0000-0001-9544-0938

Funding

TRAINING IN BIOTECHNOLOGY: EMPHASIS ON PROTEIN CHEMISTRYT32GM008336 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CALL, DOUGLAS R. · 1989 to 2023
$8.9M
REGULATION OF THE ACTIN FILAMENT POINTED END DYNAMICS IN HEALTH AND DISEASER01GM120137 · NIGMS · WASHINGTON STATE UNIVERSITY · PI GALKIN, VITOLD, GREGORIO, CAROL C · 2017 to 2024
$4.0M
MARC at Washington State UniversityT34GM141971 · NIGMS · WASHINGTON STATE UNIVERSITY · PI GIZERIAN, SAMANTHA, KOSTYUKOVA, ALLA S. · 2021 to 2025
$1.3M
Motivating Innovation and Research Achievement (MIRA)R25EB027606 · NIBIB · WASHINGTON STATE UNIVERSITY · PI Samantha Gizerian, Alla S. Kostyukova · 2020 to 2026
$1.2M
American Heart Association #826467Czarina M. & Humberto S. Lopez Endowed Chair for Excellence in Cardiovascular ResearchNIBIB NIH HHS R25 EB027606NIGMS NIH HHS R01 GM120137NIGMS NIH HHS T32 GM008336NIGMS NIH HHS T34 GM141971NIH HHS R01 GM120137
6 · The paper itself

Abstract

In cardiac muscle, regulation of actin polymerization at the thin filament pointed end is controlled by two structurally similar but functionally antagonistic proteins, leiomodin-2 and tropomodulin-1. Both proteins contain tropomyosin-binding site 1, which is essential for their recruitment to the pointed end. Using circular dichroism, we determined changes in melting temperatures (ΔTm) for complexes of tropomyosin and leiomodin-2 fragments containing several hypomorphic mutations, which moderately affect binding to tropomyosin. We ran molecular dynamics simulations for the complexes and calculated standard Gibbs free energies of binding, which we found to strongly correlate with the ΔTm. We found that the E34Q mutation in leiomodin-2 resulted in a decrease in the melting temperature of the complex of tropomyosin and leiomodin-2 fragments, indicating a decrease in the affinity of leiomodin-2 for tropomyosin. Although modest, this change in in vitro affinity made leiomodin-2 a weaker competitor for tropomyosin than tropomodulin-1 in cardiomyocytes. This mutation significantly reduced the ability of leiomodin-2 to displace tropomodulin-1 at thin filament pointed ends and affected the ability of leiomodin-2 to elongate thin filaments. Our results highlight the essential role of the tropomyosin-binding site in the dynamic equilibrium between tropomodulin-1 and leiomodin-2 at the pointed end of thin filaments. Our data also suggest the potential use of the correlation between ΔTm and the modeled standard Gibbs free energies of binding to predict changes in the stability of complexes between tropomyosin and leiomodin or tropomodulin isoforms.

Indexed as

Microfilament ProteinsTropomodulinTropomyosinAnimalsBinding SitesHumansMolecular Dynamics SimulationMutationMyocytes, CardiacProtein BindingMicrofilament ProteinsTropomodulinTropomyosin

Identifiers

PMID40272387
PMCPMC12020486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.